Efforts to secure universal access to HIV/AIDS treatment: a comparison of BRICS countries

Authors

  • Jing Sun,

    Corresponding author
    1. National Institute of Hospital Administration, National Health and Family Planning Commission (NHFPC), BRICS Medicines Alliance, Pharmaceutical Policy Research Theme Group Leader of International Network for Rational Use of Drugs (INRUD) China Core Group, China
    • Correspondence

      Jing Sun, National Institute of Hospital Administration, National Health and Family Planning Commission (NHFPC), BRICS Medicines Alliance Country Leader; Pharmaceutical Policy Research Theme Group Leader of International Network for Rational Use of Drugs (INRUD) China Core Group, 38 Xueyuan Road, Haidian District, Beijing 100191, China. Tel: +86-10-62026607; Fax: +86-10-82801614; Email: sunjingx@yahoo.com

    Search for more papers by this author
  • Alexandra Crispim Boing,

    1. Department of Public Health, Federal University of Santa Catarina, Brazil
    Search for more papers by this author
  • Marysabel PT Silveira,

    1. Instituto de Biologia, Departamento de Fisiologia e Farmacologia, Universidade Federal de Pelotas, Brazil
    Search for more papers by this author
  • Andréa D Bertoldi,

    1. Programa de Pós-graduação em Epidemiologia, Universidade Federal de Pelotas, Pelotas, RS, Brazil
    Search for more papers by this author
  • Liliya E Ziganshina,

    1. Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation
    Search for more papers by this author
  • Veronica N Khaziakhmetova,

    1. Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation
    Search for more papers by this author
  • Rashida M Khamidulina,

    1. Department of Basic and Clinical Pharmacology, Kazan Federal University, BRICS Medicines Alliance, Russian Federation
    Search for more papers by this author
  • Maulik R Chokshi,

    1. Public Health Foundation, BRICS Medicines Alliance, India
    Search for more papers by this author
  • Shelley McGee,

    1. Healthcare Policy Analyst, Market Access, SANOFI, BRICS Medicines Alliance, South Africa
    Search for more papers by this author
  • Fatima Suleman

    1. Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, BRICS Medicines Alliance, South Africa
    Search for more papers by this author

Abstract

This article illustrates how the BRICS countries have been building their focused leadership, making important high level commitment and national policy changes, and improving their health systems, in addressing the HIV/AIDS epidemics in respective settings. Specific aspects are focused on efforts of creating public provisions to secure universal access to ARVs from the aspects of active responsive system and national program, health system strengthening, fostering local production of ARVs, supply chain management, and information system strengthening. Challenges in each BRICS country are analyzed respectively. The most important contributors to the success of response to HIV/AIDS include: creating legal basis for healthcare as a fundamental human right; political commitment to necessary funding for universal access and concrete actions to secure equal quality care; comprehensive system to secure demands that all people in need are capable of accessing prevention, treatment and care; active community involvement; decentralization of the management system considering the local settings; integration of treatment and prevention; taking horizontal approach to strengthen health systems; fully use of the TRIPS flexibility; and regular monitoring and evaluation to serve evidence based decision making.

Ancillary